One thing that I don't quite understand is the fact that the original licence agreements with Lloyds would have been made based on this product being a barrier to COVID19.
Since those agreements were put in place the governing authority has stripped the product of the right to make COVID claims. Therefore this product is effectively NOT what was sold to them and as such I would assume that a new licence / agreement would now be in place with Lloyds??
We have not been provided any details of this.
Why not?
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK, page-236
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.90M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $38.00K | 387.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21590 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 39596 | 3 |
View Market Depth
| Last trade - 15.31pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |